Season 1, Episode 3

Exploring breakthroughs in treating T-cell acute lymphoblastic leukemia, the discussion highlights intensified pediatric protocols and innovative therapies, including case studies showcasing successful outcomes. It also delves into the use of a thrombopoietin agonist to address thrombocytopenia after stem cell transplants. Furthermore, the talk reveals exciting advances in microRNA-146a for targeted treatments, emphasizing its potential antitumor effects, especially in patients receiving CAR T-cell therapy.